Nasus Pharma Ltd Interest Receivable
Nasus Pharma Ltd (NSRX) had Interest Receivable of $67.00 thousand as of 2023-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Balance Sheet › Assets
us-gaap:InterestReceivable · last filed 2026-03-25
- 2023-12-31: Interest Receivable $67.00K.
| Period end | Interest Receivable |
|---|---|
| 2023-12-31 | $67.00K 20-F · filed 2026-03-25 |